Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Do we know who has been selling these last few days?

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jun 30, 2023 3:28pm

94 Views

Post# 35522828

RE:RE:RE:Do we know who has been selling these last few days?

They are not being very aggressive in selling it off, fortunately. They sold less than 10% if their holdings over the year.

LouisW wrote: Based on Taimed's financial report, Taimed is selling the TH shares.

Below is the change of shares by quarter

2022Q1, 2369572 shares -> 2022Q2, 2251582 shares ->2023Q1, 2159582 shares

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security